Literature DB >> 33468536

Activated intestinal muscle cells promote preadipocyte migration: a novel mechanism for creeping fat formation in Crohn's disease.

Ren Mao1, Genevieve Doyon2,3, Ilyssa O Gordon4, Jiannan Li3, Sinan Lin3, Jie Wang3, Thi Hong Nga Le3, Michael Elias3, Satya Kurada3, Brian Southern3, Mitchell Olman3, Minhu Chen1, Shuai Zhao3, Dina Dejanovic3, Jyotsna Chandra3, Pranab K Mukherjee3, Gail West3, David R Van Wagoner5, Claudio Fiocchi3,6, Florian Rieder7,6.   

Abstract

OBJECTIVE: Creeping fat, the wrapping of mesenteric fat around the bowel wall, is a typical feature of Crohn's disease, and is associated with stricture formation and bowel obstruction. How creeping fat forms is unknown, and we interrogated potential mechanisms using novel intestinal tissue and cell interaction systems.
DESIGN: Tissues from normal, UC, non-strictured and strictured Crohn's disease intestinal specimens were obtained. The muscularis propria matrisome was determined via proteomics. Mesenteric fat explants, primary human preadipocytes and adipocytes were used in multiple ex vivo and in vitro cell migration systems on muscularis propria muscle cell derived or native extracellular matrix. Functional experiments included integrin characterisation via flow cytometry and their inhibition with specific blocking antibodies and chemicals.
RESULTS: Crohn's disease muscularis propria cells produced an extracellular matrix scaffold which is in direct spatial and functional contact with the immediately overlaid creeping fat. The scaffold contained multiple proteins, but only fibronectin production was singularly upregulated by transforming growth factor-β1. The muscle cell-derived matrix triggered migration of preadipocytes out of mesenteric fat, fibronectin being the dominant factor responsible for their migration. Blockade of α5β1 on the preadipocyte surface inhibited their migration out of mesenteric fat and on 3D decellularised intestinal tissue extracellular matrix.
CONCLUSION: Crohn's disease creeping fat appears to result from the migration of preadipocytes out of mesenteric fat and differentiation into adipocytes in response to an increased production of fibronectin by activated muscularis propria cells. These new mechanistic insights may lead to novel approaches for prevention of creeping fat-associated stricture formation. © Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  Crohn's disease; extracellular matrix; fibrosis

Mesh:

Substances:

Year:  2021        PMID: 33468536      PMCID: PMC8286985          DOI: 10.1136/gutjnl-2020-323719

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   31.793


  41 in total

1.  Fat-wrapping in Crohn's disease: pathological basis and relevance to surgical practice.

Authors:  A L Sheehan; B F Warren; M W Gear; N A Shepherd
Journal:  Br J Surg       Date:  1992-09       Impact factor: 6.939

2.  Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement.

Authors:  M Dominici; K Le Blanc; I Mueller; I Slaper-Cortenbach; Fc Marini; Ds Krause; Rj Deans; A Keating; Dj Prockop; Em Horwitz
Journal:  Cytotherapy       Date:  2006       Impact factor: 5.414

Review 3.  Animal models of intestinal fibrosis: new tools for the understanding of pathogenesis and therapy of human disease.

Authors:  Florian Rieder; Sean Kessler; Miquel Sans; Claudio Fiocchi
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-08-09       Impact factor: 4.052

4.  Visceral fat area is associated with a high risk for early postoperative recurrence in Crohn's disease.

Authors:  Y Li; W Zhu; J Gong; W Zhang; L Gu; Z Guo; L Cao; B Shen; N Li; J Li
Journal:  Colorectal Dis       Date:  2015-03       Impact factor: 3.788

Review 5.  Obesity, inflammation, and atherosclerosis.

Authors:  Viviane Z Rocha; Peter Libby
Journal:  Nat Rev Cardiol       Date:  2009-04-28       Impact factor: 32.419

6.  Glucocorticoids antagonize tumor necrosis factor-α-stimulated lipolysis and resistance to the antilipolytic effect of insulin in human adipocytes.

Authors:  Mi-Jeong Lee; Susan K Fried
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-09-04       Impact factor: 4.310

7.  The matrisome: in silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices.

Authors:  Alexandra Naba; Karl R Clauser; Sebastian Hoersch; Hui Liu; Steven A Carr; Richard O Hynes
Journal:  Mol Cell Proteomics       Date:  2011-12-09       Impact factor: 5.911

8.  Impaired preadipocyte differentiation in human abdominal obesity: role of Wnt, tumor necrosis factor-alpha, and inflammation.

Authors:  Petter Isakson; Ann Hammarstedt; Birgit Gustafson; Ulf Smith
Journal:  Diabetes       Date:  2009-04-07       Impact factor: 9.461

9.  The generation of adipocytes by the neural crest.

Authors:  Nathalie Billon; Palma Iannarelli; Miguel Caetano Monteiro; Corinne Glavieux-Pardanaud; William D Richardson; Nicoletta Kessaris; Christian Dani; Elisabeth Dupin
Journal:  Development       Date:  2007-05-16       Impact factor: 6.868

10.  Translocation of Viable Gut Microbiota to Mesenteric Adipose Drives Formation of Creeping Fat in Humans.

Authors:  Connie W Y Ha; Anthony Martin; Gregory D Sepich-Poore; Baochen Shi; Yizhou Wang; Kenneth Gouin; Gregory Humphrey; Karenina Sanders; Yasiru Ratnayake; Kelvin S L Chan; Gustaf Hendrick; J R Caldera; Christian Arias; Jacob E Moskowitz; Shannan J Ho Sui; Shaohong Yang; David Underhill; Matthew J Brady; Simon Knott; Kelly Kaihara; Michael J Steinbaugh; Huiying Li; Dermot P B McGovern; Rob Knight; Phillip Fleshner; Suzanne Devkota
Journal:  Cell       Date:  2020-09-28       Impact factor: 41.582

View more
  7 in total

Review 1.  Intestinal strictures in Crohn's disease: a 2021 update.

Authors:  Xiaoxuan Lin; Yu Wang; Zishan Liu; Sinan Lin; Jinyu Tan; Jinshen He; Fan Hu; Xiaomin Wu; Subrata Ghosh; Minhu Chen; Fen Liu; Ren Mao
Journal:  Therap Adv Gastroenterol       Date:  2022-06-21       Impact factor: 4.802

Review 2.  Development of antifibrotic therapy for stricturing Crohn's disease: lessons from randomized trials in other fibrotic diseases.

Authors:  Si-Nan Lin; Ren Mao; Chenchen Qian; Dominik Bettenworth; Jie Wang; Jiannan Li; David H Bruining; Vipul Jairath; Brian G Feagan; Min-Hu Chen; Florian Rieder
Journal:  Physiol Rev       Date:  2021-09-27       Impact factor: 37.312

3.  Skin inflammation activates intestinal stromal fibroblasts and promotes colitis.

Authors:  Tatsuya Dokoshi; Jason S Seidman; Kellen J Cavagnero; Fengwu Li; Marc C Liggins; Bryn C Taylor; Jocelyn Olvera; Rob Knight; John T Chang; Nita H Salzman; Richard L Gallo
Journal:  J Clin Invest       Date:  2021-11-01       Impact factor: 14.808

Review 4.  Role of Adipose Tissue in Inflammatory Bowel Disease.

Authors:  Eva Karaskova; Maria Velganova-Veghova; Milos Geryk; Hana Foltenova; Veronika Kucerova; David Karasek
Journal:  Int J Mol Sci       Date:  2021-04-19       Impact factor: 5.923

Review 5.  Fibrosis in fat: From other diseases to Crohn's disease.

Authors:  Shanshan Xiong; Jinyu Tan; Yu Wang; Jinshen He; Fan Hu; Xiaomin Wu; Zishan Liu; Sinan Lin; Xuehua Li; Zhihui Chen; Ren Mao
Journal:  Front Immunol       Date:  2022-08-25       Impact factor: 8.786

Review 6.  Impact of Obesity on the Course of Management of Inflammatory Bowel Disease-A Review.

Authors:  Agata Michalak; Beata Kasztelan-Szczerbińska; Halina Cichoż-Lach
Journal:  Nutrients       Date:  2022-09-25       Impact factor: 6.706

7.  Pygopus2 ameliorates mesenteric adipocyte poor differentiation to alleviate Crohn's disease -like colitis via the Axin2/GSK3β pathway.

Authors:  Jing Li; Lugen Zuo; Zhijun Geng; Qingqing Li; Yang Cheng; Zi Yang; Ruohan Shi; Yueqing Zhou; Wenhu Nie; Yueyue Wang; Xiaofeng Zhang; Sitang Ge; Xue Song; Jianguo Hu
Journal:  Cell Prolif       Date:  2022-06-16       Impact factor: 8.755

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.